Raises Annual
GuidanceRecord Revenues of $74.0 million, up 16.9%
YOYPolicies in Force totaled approximately
378,000, up 8.7% YOYGAAP Diluted Earnings per
Share of $0.22, down 26.7% YOYAdjusted Earnings
per Share of $0.61, up 32.6% YOY
Health Insurance Innovations, Inc. (NASDAQ:HIIQ), a leading
cloud-based technology platform and distributor of affordable
individual and family health insurance and supplemental plans,
today announced financial results for the third quarter ended
September 30, 2018. The Company will host a live conference
call on Tuesday, October 30, 2018, at 8:30 A.M. EST.
Third Quarter 2018 Financial
Highlights
- Record revenue of $74.0 million, compared to $63.3 million in
the third quarter of 2017, an increase of 16.9%.
- Record total collections from members (premium equivalents) of
$114.5 million, compared to $99.4 million in the third quarter of
2017, an increase of 15.2%.
- Net income was $4.0 million, compared to $6.0 million in the
third quarter of 2017, a decrease of 33.3%.
- Adjusted EBITDA (earnings before interest, taxes, depreciation
and amortization) was $14.0 million, compared to $12.9 million in
the third quarter of 2017, an increase of 8.5%.
- GAAP diluted earnings per share was $0.22, compared to $0.30 in
the third quarter of 2017, down 26.7% YOY.
- Adjusted earnings per share, also referred to as adjusted net
income per share, or adjusted EPS, was $0.61 compared to $0.46 in
the third quarter of 2017, an increase of 32.6%.
- Policies in force as of September 30, 2018, totaled
approximately 378,000, compared to 347,900 in the third quarter of
2017, an increase of 8.7%.
Premium equivalents, adjusted EBITDA, and
adjusted EPS are non-GAAP financial measures. See the
reconciliations of these measures to their respective most directly
comparable GAAP measure included within this press release.
2018 Full Year Guidance
The Company raises its annual guidance of
revenue for 2018 to be between $294 million and $304 million, or
grow approximately 17% to 21%, year-over-year, adjusted EBITDA to
be between $56 million and $59 million, or grow approximately 24%
to 30% year-over-year, and reaffirms adjusted EPS to be between
$2.47 and $2.57, or grow approximately 50% to 56% year-over-year.
These guidance numbers are based on the Company’s current method of
accounting for revenue. As an emerging growth company, the Company
will be adopting the revised revenue recognition standard, known as
ASC 606, in the fourth quarter of 2018 for the full year ended
December 31, 2018.
"HIIQ continues to be uniquely positioned to
take advantage of the growing demand for affordable health
insurance solutions and we will continue to provide a safety net to
consumers and their families who otherwise would be unable to find
an affordable solution. We are focused to continue to be a leader
in our market and to reach as many consumers as possible. I am even
more excited about our future than I have been in the past,” said
Gavin Southwell, HIIQ's Chief Executive Officer and President.
Third Quarter 2018 Financial Discussion
Third quarter revenues of $74.0 million
increased 16.9%, compared to the third quarter in 2017, driven by
an increase in policies in force resulting from lower lapse rates,
higher average premium, favorable commission margins, and improved
discount benefit plan offerings.
Third-party commissions in the third quarter of
2018 were $46.7 million, an increase of $10.1 million, or 27.6%,
compared to the third quarter of 2017. The increases in third-party
commissions were primarily due to an increase in the number of
policies in force sold through third-party licensed
distributors.
Total selling, general & administrative
expense ("SG&A") was $18.3 million (24.7% of revenues) in the
third quarter of 2018, compared to $15.5 million (24.5% of
revenues) in the same period in 2017. Q3 SG&A included cash
severance expense of $0.7 million and $2.4 million of non-cash
based severance expense, primarily related to the termination of
HealthPocket's two founders, and higher professional fees. Core
SG&A, defined as total SG&A adjusted for stock-based
compensation, transaction costs, indemnity and other related legal
costs, severance, restructuring and other costs, and marketing
leads and advertising expense, was $9.9 million (13.3% of revenues)
in the third quarter of 2018, compared to $10.2 million (16.2% of
revenues) in the same period in 2017. A reconciliation of Core
SG&A to SG&A is included within this press release.
Net income was $4.0 million in the third quarter
of 2018, compared to $6.0 million in the same period in 2017, a
decrease of 33.3%. Third quarter 2018 included a cash severance
expense of $0.7 million. Additionally, stock-based compensation and
related costs was $1.7 million higher in the third quarter of 2018,
compared to the third quarter of 2017. EBITDA was $6.7 million in
the third quarter of 2018, compared to $9.9 million in the same
period in 2017, a decrease of 32.3%.
Adjusted EBITDA was $14.0 million in the third
quarter of 2018, an increase of 8.5%, compared to $12.9 million in
the same period in 2017. Adjusted EBITDA as a percentage of revenue
was 18.9%, in the third quarter of 2018, compared to 20.4% in the
same period in 2017. Adjusted EBITDA is calculated by taking EBITDA
and adjusting for items such as stock-based compensation and
related costs and items that are not part of regular operating
activities, including indemnity and other related legal costs,
severance, restructuring, and acquisition costs. A reconciliation
of net income to EBITDA and adjusted EBITDA for the three and nine
months ended September 30, 2018 and 2017 is included within this
press release.
GAAP diluted EPS for the third quarter of 2018
was $0.22, compared to $0.30 in the same period in 2017. Third
quarter 2018 GAAP diluted EPS was unfavorably impacted by the
above-described severance expense and higher stock-based
compensation.
Adjusted EPS for the third quarter of 2018 was
$0.61, compared to $0.46 in 2017. The increase in Adjusted EPS was
driven by higher revenue from greater policies in force, continued
scalability as well as a lower pro-forma statutory tax rate of 24%,
compared to 38% used in the prior period. A reconciliation of net
income to adjusted net income per share is included within this
press release.
The Company makes advances to distributors based
on actual sales. These advanced commissions assist distributors
with working capital. The Company recovers advances on an ongoing
basis from future commissions on premiums, which are collected over
the period in which policies renew. At September 30, 2018, the
short- and long-term advanced commission balance was $42.7 million,
a $3.2 million increase from the December 31, 2017 year-end
balance of $39.5 million.
Cash and cash equivalents as of
September 30, 2018 totaled $33.1 million, a decrease of $7.8
million from the December 31, 2017 year-end balance. The
Company repurchased 310,890 shares of its common stock in the third
quarter of 2018 for $15.7 million as part of its previously
announced share repurchase program.
Regulatory Update
As previously disclosed, the Company is the
subject of a multistate market conduct examination (MCE). On
October 3, 2018 the Company met with the MCE examiners for
confidential settlement discussions. These discussions included
updated feedback on the results of the examination, and discussion
aimed toward potential resolution of the examination. The Company
has made what it believes to be an appropriate accrual based on the
nature and stage of current discussions with the MCE examiners.
Under the rules of the MCE, the negotiations remain
confidential.
Revenue Recognition Update
The Company will be adopting the revised revenue
recognition standard, known as ASC 606, in the fourth quarter of
2018 for the full year ended December 31, 2018.
Under the standard, we have determined that we
have two groups of performance obligations, which we define as:
Sales and Enrollment, and Billing and Collecting / Member Support.
While our adoption of ASC 606 will not change how our business
operates, we believe that our adoption of this standard will have a
material impact on our consolidated financial statements by
bringing forward how we recognize revenue. We will now
recognize the sales and enrollment component of our revenue at a
point in time, or upfront, based on the amount of the total
estimated lifetime duration for each insurance product or discount
benefit plan that we sell. We will continue to recognize the
billing, collection and customer service component of our revenue
over time as we continue to perform these services. The sales
and enrollment component of our revenue in any given quarter will
be driven almost exclusively by new enrollments that we generate
during the quarter. We plan to restate the 2018 year-to-date
financial statements with our fourth quarter 2018 earnings
release.
Conference Call and Webcast
The Company will host an earnings conference
call on October 30, 2018 at 8:30 A.M. Eastern time. All interested
parties can join the call by dialing (877) 451-6152 or
(201) 389-0879; the conference ID is 13684258. A webcast
of the call may be accessed in the Investor Relations section of
Health Insurance Innovations’ website at
http://investor.hiiquote.com/. An archive of the call will be
available for 30 days through the same website.
About Health Insurance Innovations, Inc.
(HIIQ)
HIIQ is a market leading cloud-based technology
platform and distributor of innovative health insurance products
that are affordable and meet the consumer's needs. HIIQ helps
develop insurance products through our relationships with
best-in-class insurance companies and markets them via its broad
distribution network of third-party licensed insurance agents
across the nation, its call center network and its unique online
capability. Additional information about HIIQ can be found at
HIIQ.com. HIIQ’s Consumer Division includes
AgileHealthInsurance.com, a website for researching, comparing and
purchasing short-term health insurance products online and
HealthPocket.com, a free website that compares and ranks all health
insurance plans, and uses objective data to publish unbiased health
insurance market analyses and other consumer advocacy research.
Forward-Looking Statements
This press release contains "forward-looking
statements" within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Forward-looking statements are
statements other than historical fact, and may include statements
relating to goals, plans and projections regarding new markets,
products, services, growth strategies, anticipated trends in our
business and anticipated changes and developments in the United
States health insurance system and laws. Forward-looking statements
are based on HIIQ’s current assumptions, expectations and beliefs
are generally identifiable by use of words “may,” “might,” “will,”
“should,” “expects,” “plans,” “anticipates,” “believes,”
“estimates,” “predicts,” “potential” or “continue,” or similar
expressions and involve significant risks and uncertainties that
could cause actual results, developments and business decisions to
differ materially from those contemplated by these statements.
These risks and uncertainties include, among other things, our
ability to maintain relationships and develop new relationships
with health insurance carriers and distributors, our ability to
retain our members, the demand for products offered through our
platform, state regulatory oversight and examinations of us and our
carriers and distributors, legal and regulatory compliance by our
carriers and distributors, the amount of commissions paid to us or
changes in health insurance plan pricing practices, competition,
changes and developments in the United States health insurance
system and laws, and HIIQ’s ability to adapt to them, the ability
to maintain and enhance our name recognition, difficulties arising
from acquisitions or other strategic transactions, and our ability
to build the necessary infrastructure and processes to maintain
effective controls over financial reporting. These and other risk
factors that could cause actual results to differ materially from
those expressed or implied in our forward-looking statements will
be discussed in HIIQ's Annual Report on Form 10-K filed with the
Securities and Exchange Commission (SEC) as well as other documents
that may be filed by HIIQ from time to time with the Securities and
Exchange Commission, which are available at www.sec.gov. Any
forward-looking statement made by us in this press release is based
only on information currently available to us and speaks only as of
the date on which it is made. You should not rely on any
forward-looking statement as representing our views in the future.
We undertake no obligation to publicly update any forward-looking
statement, whether written or oral, that may be made from time to
time, whether as a result of new information, future developments
or otherwise.
Non-GAAP Financial
Information
To supplement HIIQ’s financial information
presented in accordance with generally accepted accounting
principles in the United States of America, or GAAP, HIIQ presents
certain financial measures that are not prepared in accordance with
GAAP, including premium equivalents, adjusted EBITDA, adjusted EPS,
and Core SG&A. These non-GAAP financial measures, which are
defined below, should not be considered in isolation from, or as a
substitute for, financial information prepared in accordance with
GAAP. These non-GAAP financial measures are not based on any
standardized methodology prescribed by GAAP and are not necessarily
comparable to similarly-titled measures presented by other
companies.
HIIQ is presenting these non-GAAP financial
measures to assist investors in seeing HIIQ’s operating results
through the eyes of management and because HIIQ believes that these
measures provide a useful tool for investors to use in assessing
HIIQ’s operating performance against prior period operating results
and against business objectives. HIIQ uses the non-GAAP financial
measures in evaluating its operating results and for financial and
operational decision-making purposes.
The accompanying tables provide more detail on
the GAAP financial measures that are most directly comparable to
the non-GAAP financial measures described above and the related
reconciliations between these financial measures.
|
|
|
|
HEALTH INSURANCE
INNOVATIONS, INC. |
Condensed Consolidated
Balance Sheets |
($ in thousands, except
share and per share data) |
|
|
|
|
|
September 30,
2018 |
|
December 31,
2017 |
|
(unaudited) |
|
|
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ |
33,135 |
|
|
$ |
40,907 |
|
Restricted cash |
15,140 |
|
|
14,920 |
|
Accounts receivable, net, prepaid expenses and other
current assets |
2,661 |
|
|
2,227 |
|
Advanced commissions, net |
38,270 |
|
|
39,549 |
|
Income taxes receivable |
2,542 |
|
|
— |
|
Total current assets |
91,748 |
|
|
97,603 |
|
Long-term advanced commissions |
4,380 |
|
|
— |
|
Property and equipment, net |
5,400 |
|
|
5,408 |
|
Goodwill |
41,076 |
|
|
41,076 |
|
Intangible assets, net |
4,551 |
|
|
5,942 |
|
Deferred tax assets |
26,160 |
|
|
14,960 |
|
Other assets |
77 |
|
|
96 |
|
Total assets |
$ |
173,392 |
|
|
$ |
165,085 |
|
|
|
|
|
Liabilities and stockholders’ equity |
|
|
|
Current liabilities: |
|
|
|
Accounts payable and accrued expenses |
$ |
37,741 |
|
|
$ |
39,725 |
|
Deferred revenue |
221 |
|
|
662 |
|
Income taxes payable |
— |
|
|
787 |
|
Due to member |
1,137 |
|
|
1,775 |
|
Other current liabilities |
11 |
|
|
5 |
|
Total current liabilities |
39,110 |
|
|
42,954 |
|
Due to member |
26,293 |
|
|
15,096 |
|
Other liabilities |
18 |
|
|
34 |
|
Total liabilities |
65,421 |
|
|
58,084 |
|
Commitments and contingencies |
|
|
|
Stockholders’ equity: |
|
|
|
Class A common stock (par value $0.001 per share, 100,000,000
shares authorized; 14,405,824 and 12,731,758 shares issued as of
September 30, 2018 and December 31, 2017, respectively; 13,515,203
and 12,350,981 shares outstanding as of September 30, 2018 and
December 31, 2017, respectively) |
14 |
|
|
13 |
|
Class B common stock (par value $0.001 per share, 20,000,000 shares
authorized; 2,541,667 and 3,841,667 shares issued and outstanding
as of September 30, 2018 and December 31, 2017, respectively) |
3 |
|
|
4 |
|
Preferred stock (par value $0.001 per share, 5,000,000 shares
authorized; no shares issued and outstanding as of September 30,
2018 and December 31, 2017) |
— |
|
|
— |
|
Additional paid-in capital |
91,960 |
|
|
71,770 |
|
Treasury stock, at cost (890,621 and 380,777 shares as of September
30, 2018 and December 31, 2017, respectively) |
(29,859 |
) |
|
(6,887 |
) |
Retained earnings |
29,361 |
|
|
19,305 |
|
Total Health Insurance Innovations, Inc.
stockholders’ equity |
91,479 |
|
|
84,205 |
|
Noncontrolling interests |
16,492 |
|
|
22,796 |
|
Total stockholders’ equity |
107,971 |
|
|
107,001 |
|
Total liabilities and stockholders' equity |
$ |
173,392 |
|
|
$ |
165,085 |
|
|
|
|
|
|
|
|
|
HEALTH INSURANCE
INNOVATIONS, INC. |
Condensed Consolidated
Statements of Income (unaudited) |
($ in thousands, except
share and per share data) |
|
|
|
|
|
Three Months Ended September
30, |
|
Nine Months Ended
September 30, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
Revenues (premium equivalents of $114,498 and $99,407 for the three
months ended September 30, 2018 and 2017, respectively and $330,633
and $289,243 for the nine months ended September 30, 2018 and 2017,
respectively) |
$ |
74,013 |
|
|
$ |
63,335 |
|
|
$ |
213,487 |
|
|
$ |
180,986 |
|
Operating expenses: |
|
|
|
|
|
|
|
Third-party commissions |
46,695 |
|
|
36,603 |
|
|
131,792 |
|
|
103,146 |
|
Credit card and ACH fees |
1,570 |
|
|
1,289 |
|
|
4,318 |
|
|
3,704 |
|
Selling, general and administrative |
18,260 |
|
|
15,503 |
|
|
54,197 |
|
|
45,457 |
|
Depreciation and amortization |
1,270 |
|
|
1,028 |
|
|
3,655 |
|
|
2,958 |
|
Total operating expenses |
67,795 |
|
|
54,423 |
|
|
193,962 |
|
|
155,265 |
|
Income from operations |
6,218 |
|
|
8,912 |
|
|
19,525 |
|
|
25,721 |
|
|
|
|
|
|
|
|
|
Other (income) expense: |
|
|
|
|
|
|
|
Interest (income) expense |
15 |
|
|
(2 |
) |
|
(39 |
) |
|
(2 |
) |
TRA expense |
721 |
|
|
— |
|
|
721 |
|
|
— |
|
Other expense |
29 |
|
|
23 |
|
|
88 |
|
|
27 |
|
Net income before income taxes |
5,453 |
|
|
8,891 |
|
|
18,755 |
|
|
25,696 |
|
Provision for income taxes |
1,466 |
|
|
2,889 |
|
|
4,757 |
|
|
4,220 |
|
Net income |
3,987 |
|
|
6,002 |
|
|
13,998 |
|
|
21,476 |
|
Net income attributable to noncontrolling
interests |
943 |
|
|
2,117 |
|
|
3,942 |
|
|
7,374 |
|
Net income attributable to Health Insurance Innovations, Inc. |
$ |
3,044 |
|
|
$ |
3,885 |
|
|
$ |
10,056 |
|
|
$ |
14,102 |
|
|
|
|
|
|
|
|
|
Per share data: |
|
|
|
|
|
|
|
Net income per share attributable to Health Insurance
Innovations, Inc. |
|
|
|
|
|
|
|
Basic |
$ |
0.24 |
|
|
$ |
0.33 |
|
|
$ |
0.83 |
|
|
$ |
1.31 |
|
Diluted |
$ |
0.22 |
|
|
$ |
0.30 |
|
|
$ |
0.76 |
|
|
$ |
1.21 |
|
Weighted average Class A common shares
outstanding |
|
|
|
|
|
|
|
Basic |
12,853,739 |
|
|
11,700,941 |
|
|
12,130,722 |
|
|
10,724,750 |
|
Diluted |
14,060,453 |
|
|
12,742,952 |
|
|
13,302,811 |
|
|
11,692,755 |
|
|
|
|
|
|
|
|
|
|
|
|
|
HEALTH INSURANCE
INNOVATIONS, INC. |
Condensed Consolidated
Statements of Cash Flows (unaudited) |
($ in thousands, except
share and per share data) |
|
|
|
Nine Months Ended
September 30, |
|
2018 |
|
2017 |
Operating activities: |
|
|
|
Net income |
$ |
13,998 |
|
|
$ |
21,476 |
|
Adjustments to reconcile net income to net cash provided by
operating activities: |
|
|
|
Stock-based compensation |
10,503 |
|
|
4,437 |
|
Depreciation and amortization |
3,655 |
|
|
2,958 |
|
Loss on disposal of assets |
1 |
|
|
— |
|
Deferred income taxes |
460 |
|
|
1,079 |
|
Changes in operating assets and liabilities: |
|
|
|
(Increase) decrease in accounts receivable, prepaid
expenses and other assets |
(398 |
) |
|
96 |
|
(Increase) decrease in advanced commissions |
(3,101 |
) |
|
9,991 |
|
Increase in income taxes receivable |
(2,542 |
) |
|
— |
|
Decrease in income taxes payable |
(787 |
) |
|
(935 |
) |
(Decrease) increase in accounts payable, accrued
expenses and other liabilities |
(1,994 |
) |
|
1,682 |
|
Decrease in deferred revenue |
(441 |
) |
|
(173 |
) |
Increase in due to member pursuant to tax receivable
agreement |
721 |
|
|
— |
|
Net cash provided by operating activities |
20,075 |
|
|
40,611 |
|
Investing activities: |
|
|
|
Capitalized internal-use software |
(1,290 |
) |
|
(2,104 |
) |
Purchases of property and equipment |
(534 |
) |
|
(239 |
) |
Net cash used in investing activities |
(1,824 |
) |
|
(2,343 |
) |
Financing activities: |
|
|
|
Payments for noncompete obligation |
— |
|
|
(96 |
) |
Payments related to tax withholding for share-based
compensation |
(3,470 |
) |
|
(448 |
) |
Issuances of Class A common stock under equity
compensation plans |
6 |
|
|
32 |
|
Purchases of Class A common stock pursuant to share
repurchase plan |
(19,502 |
) |
|
— |
|
Distributions to member |
(2,837 |
) |
|
(5,318 |
) |
Net cash used in financing activities |
(25,803 |
) |
|
(5,830 |
) |
Net (decrease) increase in cash and cash equivalents, and
restricted cash |
(7,552 |
) |
|
32,438 |
|
Cash and cash equivalents, and restricted cash at beginning of
period |
55,827 |
|
|
25,370 |
|
Cash and cash equivalents, and restricted cash at end of
period |
$ |
48,275 |
|
|
$ |
57,808 |
|
|
|
|
|
Supplemental cash flow information: |
|
|
|
Cash paid during the period for: |
|
|
|
Income taxes, net |
$ |
7,651 |
|
|
$ |
4,113 |
|
Interest |
6 |
|
|
10 |
|
Non-cash investing activities: |
|
|
|
Capitalized stock-based compensation |
$ |
433 |
|
|
$ |
— |
|
Loss on disposal of assets |
1 |
|
|
$ |
— |
|
Non-cash financing activities: |
|
|
|
Change in due to member related to Exchange
Agreement |
$ |
10,476 |
|
|
$ |
18,619 |
|
Change in deferred tax asset related to Exchange
Agreement |
(11,661 |
) |
|
(20,732 |
) |
Issuance of Class A common stock in a private
offering related to Exchange Agreement |
9,232 |
|
|
16,487 |
|
Exchange of Class B membership interests related to
Exchange Agreement |
(8,048 |
) |
|
(14,374 |
) |
|
|
|
|
|
|
Reconciliation of Net
Income to EBITDA and Adjusted EBITDA |
(unaudited) |
($ in
thousands) |
|
|
|
|
|
Three Months Ended September
30, |
|
Nine Months Ended September 30, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
Net income |
$ |
3,987 |
|
|
$ |
6,002 |
|
|
$ |
13,998 |
|
|
$ |
21,476 |
|
Interest (income) expense |
15 |
|
|
(2 |
) |
|
(39 |
) |
|
(2 |
) |
Depreciation and amortization |
1,270 |
|
|
1,028 |
|
|
3,655 |
|
|
2,958 |
|
Provision for income taxes |
1,466 |
|
|
2,889 |
|
|
4,757 |
|
|
4,220 |
|
EBITDA (1) |
6,738 |
|
|
9,917 |
|
|
22,371 |
|
|
28,652 |
|
Stock-based compensation and related costs |
4,500 |
|
|
2,782 |
|
|
10,766 |
|
|
4,897 |
|
Transaction costs |
64 |
|
|
5 |
|
|
283 |
|
|
761 |
|
Tax receivable agreement liability adjustment |
721 |
|
|
— |
|
|
721 |
|
|
— |
|
Indemnity and other related legal costs |
1,301 |
|
|
238 |
|
|
2,334 |
|
|
886 |
|
Severance, restructuring and other charges |
706 |
|
|
— |
|
|
3,658 |
|
|
247 |
|
Adjusted EBITDA (2) |
$ |
14,030 |
|
|
$ |
12,942 |
|
|
$ |
40,133 |
|
|
$ |
35,443 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Net
Income to Adjusted Net Income per Share |
(unaudited) |
($ in thousands
except per share data) |
|
|
|
|
|
Three Months Ended September
30, |
|
Nine Months Ended September
30, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
Net income |
$ |
3,987 |
|
|
$ |
6,002 |
|
|
$ |
13,998 |
|
|
$ |
21,476 |
|
Interest (income) expense |
15 |
|
|
(2 |
) |
|
(39 |
) |
|
(2 |
) |
Amortization |
464 |
|
|
479 |
|
|
1,391 |
|
|
1,502 |
|
Provision for income taxes |
1,466 |
|
|
2,889 |
|
|
4,757 |
|
|
4,220 |
|
Stock-based compensation and related costs |
4,500 |
|
|
2,782 |
|
|
10,766 |
|
|
4,897 |
|
Transaction costs |
64 |
|
|
5 |
|
|
283 |
|
|
761 |
|
Tax receivable agreement liability adjustment |
721 |
|
|
— |
|
|
721 |
|
|
— |
|
Indemnity and other related legal costs |
1,301 |
|
|
238 |
|
|
2,334 |
|
|
886 |
|
Severance, restructuring and other charges |
706 |
|
|
— |
|
|
3,658 |
|
|
247 |
|
Adjusted pre-tax income |
13,224 |
|
|
12,393 |
|
|
37,869 |
|
|
33,987 |
|
Pro forma income taxes |
(3,174 |
) |
|
(4,709 |
) |
|
(9,089 |
) |
|
(12,915 |
) |
Adjusted net income (3) |
$ |
10,050 |
|
|
$ |
7,684 |
|
|
$ |
28,780 |
|
|
$ |
21,072 |
|
Total weighted average diluted share count |
16,602 |
|
|
16,585 |
|
|
16,592 |
|
|
16,260 |
|
Adjusted net income per share (4) |
$ |
0.61 |
|
|
$ |
0.46 |
|
|
$ |
1.73 |
|
|
$ |
1.30 |
|
- EBITDA is defined as net income before interest expense, income
taxes and depreciation and amortization. We have included EBITDA in
this report because it is a key measure used by our management and
Board of Directors to understand and evaluate our core operating
performance and trends, to prepare and approve our annual budget
and to develop short- and long-term operational plans. In
particular, the exclusion of certain expenses in calculating EBITDA
can provide a useful measure for period-to-period comparisons of
our business. However, EBITDA does not represent, and should not be
considered as, an alternative to net income or cash flows from
operations, each as determined in accordance with generally
accepted accounting principles in the United States of America
(“GAAP”). Other companies may calculate EBITDA differently than we
do. EBITDA has limitations as an analytical tool, and you should
not consider it in isolation or as a substitute for analysis of our
results as reported under GAAP.
- To calculate adjusted EBITDA, we calculate EBITDA, which is
then further adjusted for items such as stock-based compensation
and related costs and items that are not part of regular operating
activities, including tax receivable adjustments, severance,
restructuring, indemnity and other related legal costs, and
acquisition costs. Adjusted EBITDA does not represent, and should
not be considered as, an alternative to net income or cash flows
from operations, each as determined in accordance with GAAP. We
have presented adjusted EBITDA because we consider it an important
supplemental measure of our performance and believe that it is
frequently used by analysts, investors and other interested parties
in the evaluation of companies. Other companies may calculate
adjusted EBITDA differently than we do. Adjusted EBITDA has
limitations as an analytical tool, and you should not consider it
in isolation or as a substitute for analysis of our results as
reported under GAAP.
- To calculate adjusted net income, we calculate net income then
add back amortization (but not depreciation), interest, tax
expense, stock-based compensation and related costs, and other
items that are not part of regular operating activities, including,
tax receivable adjustments, severance, restructuring, indemnity and
other related legal costs, and acquisition costs. From adjusted
pre-tax net income we apply a pro-forma tax expense calculated at
an assumed rate of 24% for the three and nine months ended
September 30, 2018 and 38% for the three and nine months ended
September 30, 2017. We believe that when measuring Company and
executive performance against the adjusted net income measure,
applying a pro forma tax rate better reflects the performance of
the Company without regard to the Company’s organizational tax
structure. We have included adjusted net income in this report
because it is a key performance measure used by our management to
understand and evaluate our core operating performance and trends
and because we believe it is frequently used by analysts, investors
and other interested parties in their evaluation of our company.
Other companies may calculate this measure differently than we do.
Adjusted net income has limitations as an analytical tool, and you
should not consider it in isolation or substitution for earnings
per share as reported under GAAP.
- Adjusted net income per share is computed by dividing adjusted
net income by the total number of diluted Class A and Class B
shares of our common stock for each period. We have included
adjusted net income per share in this report because it is a key
measure used by our management to understand and evaluate our core
operating performance and trends and because we believe it is
frequently used by analysts, investors and other interested parties
in the evaluation of companies. Other companies may calculate this
measure differently than we do. Adjusted net income per share has
limitations as an analytical tool, and you should not consider it
in isolation or as a substitute for earnings per share as reported
under GAAP.
|
|
|
|
Reconciliation of Premium
Equivalents to Revenues |
(unaudited) |
($ in
thousands) |
|
|
|
|
|
Three Months Ended September
30, |
|
Nine Months Ended September
30, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
Premium equivalents (1) |
$ |
114,498 |
|
|
$ |
99,407 |
|
|
$ |
330,633 |
|
|
$ |
289,243 |
|
Less risk premium |
38,569 |
|
|
34,502 |
|
|
111,685 |
|
|
103,545 |
|
Less amounts earned by third party obligors |
1,916 |
|
|
1,570 |
|
|
5,461 |
|
|
4,712 |
|
Revenues |
$ |
74,013 |
|
|
$ |
63,335 |
|
|
$ |
213,487 |
|
|
$ |
180,986 |
|
- Premium equivalents is defined as our total collections,
including the combination of premiums, fees for discount benefit
plans, third-party commissions and referral fees. All amounts not
paid out as risk premium to carriers or paid out to other
third-party obligors are considered to be revenues for financial
reporting purposes. We have included premium equivalents in this
report because it is a key measure used by our management to
understand and evaluate our core operating performance and trends,
to prepare and approve our annual budget, and to develop short- and
long-term operational plans. In particular, the inclusion of
premium equivalents can provide a useful measure for
period-to-period comparisons of our business. This financial
measurement is considered a non-GAAP financial measure and is not
recognized under generally accepted accounting principles in the
United States of America (“GAAP”) and should not be used as, and is
not an alternative to, revenues as a measure of our operating
performance.
|
|
|
|
Summary of Selected
Metrics |
(unaudited) |
($ in
thousands) |
|
|
|
|
|
Submitted Applications
during the Three Months Ended September 30, |
|
|
|
2018 |
|
2017 |
|
Change |
IFP |
80,500 |
|
93,100 |
|
(13.5 |
)% |
Supplemental products |
57,000 |
|
60,800 |
|
(6.3 |
)% |
Total |
137,500 |
|
153,900 |
|
(10.7 |
)% |
|
Policies in Force as of
September 30, |
|
|
|
2018 |
|
2017 |
|
Change |
IFP |
192,700 |
|
|
176,100 |
|
|
9.4 |
% |
Supplemental products |
185,300 |
|
|
171,800 |
|
|
7.9 |
% |
Total |
378,000 |
|
|
347,900 |
|
|
8.7 |
% |
|
Submitted IFP Applications
by Channel |
|
Q3’17 |
|
Q4’17 |
|
Q1’18 |
|
Q2’18 |
|
Q3’18 |
eCommerce |
20,600 |
|
27,200 |
|
18,900 |
|
18,700 |
|
17,700 |
All Others |
72,500 |
|
98,600 |
|
73,100 |
|
73,400 |
|
62,800 |
Total |
93,100 |
|
125,800 |
|
92,000 |
|
92,100 |
|
80,500 |
|
Core SG&A as a Percentage of
Revenue |
|
Q3’17 |
|
Q4’17 |
|
Q1’18 |
|
Q2’18 |
|
Q3'18 |
Total SG&A |
15,503 |
|
18,989 |
|
|
16,213 |
|
19,724 |
|
18,260 |
Less: Stock-based
compensation and related costs |
2,782 |
|
2,993 |
|
|
2,633 |
|
3,601 |
|
4,500 |
Less (add): Transaction
costs |
5 |
|
(16 |
) |
|
56 |
|
163 |
|
64 |
Less: Indemnity and
other related legal costs |
238 |
|
672 |
|
|
287 |
|
745 |
|
1,301 |
Less: Severance,
restructuring and other charges |
— |
|
|
— |
|
|
— |
|
|
2,952 |
|
706 |
Less: Marketing and
Advertising |
2,249 |
|
3,657 |
|
|
2,232 |
|
2,071 |
|
1,839 |
Core SG&A (1) |
10,229 |
|
11,683 |
|
|
11,005 |
|
10,192 |
|
9,850 |
% of Revenue |
16.2 |
% |
|
16.8 |
% |
|
16.2 |
% |
|
14.2 |
% |
|
13.3 |
% |
- Core SG&A is defined as total SG&A adjusted for
stock-based compensation and related costs, transaction costs,
indemnity and other related legal costs, severance, restructuring
and other charges, and marketing leads and advertising
expense.
Contacts:
Health Insurance Innovations, Inc.:Michael HershbergerChief
Financial Officer(813) 397-1187mhershberger@hiiq.com
Investor Contact:John EvansPIR Communications(415)
309-0230IR@hiiquote.com
Health Insurance Innovat... (NASDAQ:HIIQ)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Health Insurance Innovat... (NASDAQ:HIIQ)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024